Impact
BioMedical SIG #8
Nadina Grosios outlines the regulatory path from academic drug discovery to market, highlighting key studies and concepts that support clinical trial submissions, funding access, and partnership building.
Search for resources
Impact
BioMedical SIG #7
Philippe Tschopp explored how aligning manufacturing design with regulatory and clinical strategy enhances the development of oral solid drug products. He focused on GMP, GLP, and TPP as key components for ensuring quality, safety, and scalability.
Impact
BioMedical SIG #6
Thomas Hanke (Evotec) shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology company specialising in collaborative drug discovery—Hanke highlights best practices to align early-stage research with potential clinical applications.
Journals and Articles
New Frontiers in oncology: an evolving innovation ecosystem
A new study from the European Patent Office (EPO) explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem provides a comprehensive analysis of patent trends in cancer-related technologies, revealing both the strengths and challenges facing Europe in this critical field.
Impact
BioMedical SIG #4
Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements.
Impact
BioMedical SIG #3
Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.
Impact
BioMedical SIG #2
Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.
Impact
BioMedical SIG #1
First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.
Journals and Articles
Innovation in water-related technologies
This EPO study gives insights into trends in innovation in water-related technologies aimed at both the provision of and protection from water.
Impact
Digital Innovations SIG: World Lunch #6
With Laura Spinardi, Head of Technology Transfer Office, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, we discussed the challenges of managing data in digital clinical research: not just the privacy/personal data issues, but also data management and data sharing within collaborative research projects, using data for machine learning and training, and the ease or difficulty of transferring data in licensing and spin out opportunities.
Impact
Digital Innovations SIG: World Lunch #5
Michiel Hulsbergen is CEO and founder of DialogueTrainer. In this edition of the Digital Innovation SIG World Lunch, Michiel shared the challenges he has faced setting up and running the company. As a spin-out from the Utrecht University, how did he navigate the issues of IP, funding and commercial development?
Toolbox
Doing Business in the United States
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.